Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Prostatic Neoplasms × tazemetostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcoma 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Sarcoma, Synovial 3 Rhabdoid Tumor 3 Lymphoma, B-Cell 3 Recurrence 2 Mesothelioma 2 Lymphoma, Non-Hodgkin 2 Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Nerve Sheath Neoplasms 1 Medulloblastoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Inhibition, Psychological 1 Hodgkin Disease 1 Histiocytosis, Langerhans-Cell 1 Hepatoblastoma 1 Hematologic Neoplasms 1 Glioma 1 Ependymoma 1 Central Nervous System Neoplasms 1

Interventions

Prednisone 101 Docetaxel 79 Leuprolide 72 Abiraterone Acetate 62 enzalutamide 59 bicalutamide 44 Goserelin 44 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 38 Radiotherapy 33 gallium 68 PSMA-11 21 apalutamide 21 abiraterone 21 Magnetic Resonance Spectroscopy 21 Gonadotropin-Releasing Hormone 21 luprolide acetate gel depot 19 sipuleucel-T 18 Androgen Antagonists 18 Triptorelin Pamoate 17 Radiosurgery 17 cabazitaxel 15 Radiotherapy, Intensity-Modulated 14 pembrolizumab 13 cabozantinib 13 Prednisolone 12 Flutamide 12 Dexamethasone 12 Brachytherapy 12 radium Ra 223 dichloride 11 fluciclovine F-18 11 Radiation 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04179864 2026-03-10

CELLO-1

Ipsen

Phase 1/2 Terminated

102 enrolled 39 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡